Logo
x

Search

Subscribe Now

usfda

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

Pfizer Reports NDA Submission of Paxlovid to the US FDA for the Treatment of COVID-19

  • July 1, 2022
Aeglea Biotherapeutics Achieves Primary Endpoint in P-III study of Pegzilarginase in patients with Arginase 1 Deficiency

Aeglea Biotherapeutics Achieves Primary Endpoint in P-III study of Pegzilarginase in patients with Arginase 1 Deficiency

  • December 6, 2021
Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD in Patients with Hemodialysis

Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD...

  • August 25, 2021
Novartis's Entresto Receives the US FDA's Advisory Committee Recommendation to Treat Patients with HFpEF

Novartis's Entresto Receives the US FDA's Advisory Committee Recommendation to Treat Patients with HFpEF

  • December 17, 2020
Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

  • December 16, 2020
Samsung Bioepis and Biogen Report the FDA's Acceptance of BLA for SB11 Proposed Biosimilar to Lucentis

Samsung Bioepis and Biogen Report the FDA's Acceptance of BLA for SB11 Proposed Biosimilar to Lucentis

  • November 18, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.